Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2008

01.10.2008 | Clinical-Patienet Studies

Long-term outcome of conventional radiation therapy for central neurocytoma

verfasst von: Sun Ha Paek, Jung-Ho Han, Jin Wook Kim, Chul-Kee Park, Hee-Won Jung, Sung-Hye Park, Il Han Kim, Dong Gyu Kim

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

The authors report the long-term outcome of conventional radiation therapy (RT) in six cases of central neurocytoma (CN). Between 1985 and 1992, six patients were treated with RT for residual tumors or for prevention of recurrence after surgery. The median follow-up period of radiological and clinical status were 171 (range: 128–229) and 202 months (range: 165–227), respectively. Tumors disappeared in three and reduced in three patients at the last follow-up. One-mortality case due to radiation necrosis and one radiation-induced malignancy occurred. White matter degeneration and cortical atrophy were noticed with slow progression of performance deterioration in two patients. Conventional RT seemed to effectively control residual CN after surgery. However, more sophisticated radiation techniques should be applied to minimize the late sequela.
Literatur
1.
Zurück zum Zitat Hassoun J, Gambarelli D, Grisoli F et al (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 56:151–156CrossRefPubMed Hassoun J, Gambarelli D, Grisoli F et al (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 56:151–156CrossRefPubMed
2.
Zurück zum Zitat Kim DG, Chi JG, Park SH et al (1992) Intraventricular neurocytoma: clinicopathological analysis of seven cases. J Neurosurg 76:759–765CrossRefPubMed Kim DG, Chi JG, Park SH et al (1992) Intraventricular neurocytoma: clinicopathological analysis of seven cases. J Neurosurg 76:759–765CrossRefPubMed
3.
Zurück zum Zitat Bertalanffy A, Roessler K, Koperek O et al (2005) Recurrent central neurocytomas. Cancer 104:135–142CrossRefPubMed Bertalanffy A, Roessler K, Koperek O et al (2005) Recurrent central neurocytomas. Cancer 104:135–142CrossRefPubMed
4.
Zurück zum Zitat Kim DG, Paek SH, Kim IH et al (1997) Central neurocytoma: the role of radiation therapy and long term outcome. Cancer 79:1995–2002CrossRefPubMed Kim DG, Paek SH, Kim IH et al (1997) Central neurocytoma: the role of radiation therapy and long term outcome. Cancer 79:1995–2002CrossRefPubMed
5.
Zurück zum Zitat Kulkarni V, Rajshekhar V, Haran RP et al (2002) Long-term outcome in patients with central neurocytoma following stereotactic biopsy and radiation therapy. Br J Neurosurg 16:126–132CrossRefPubMed Kulkarni V, Rajshekhar V, Haran RP et al (2002) Long-term outcome in patients with central neurocytoma following stereotactic biopsy and radiation therapy. Br J Neurosurg 16:126–132CrossRefPubMed
6.
Zurück zum Zitat Nakagawa K, Aoki Y, Sakata K et al (1993) Radiation therapy of well-differentiated neuroblastoma and central neurocytoma. Cancer 72:1350–1355CrossRefPubMed Nakagawa K, Aoki Y, Sakata K et al (1993) Radiation therapy of well-differentiated neuroblastoma and central neurocytoma. Cancer 72:1350–1355CrossRefPubMed
7.
Zurück zum Zitat Rades D, Schild SE, Ikezaki K et al (2003) Defining the optimal dose of radiation after incomplete resection of central neurocytomas. Int J Radiat Oncol Biol Phys 55:373–377CrossRefPubMed Rades D, Schild SE, Ikezaki K et al (2003) Defining the optimal dose of radiation after incomplete resection of central neurocytomas. Int J Radiat Oncol Biol Phys 55:373–377CrossRefPubMed
8.
Zurück zum Zitat Fujimaki T, Matsuno A, Sasaki T et al (1997) Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index. J Neurooncol 32:103–109CrossRefPubMed Fujimaki T, Matsuno A, Sasaki T et al (1997) Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index. J Neurooncol 32:103–109CrossRefPubMed
9.
Zurück zum Zitat Pollock BE, Stafford SL (2001) Stereotactic radiosurgery for recurrent central neurocytoma: case report. Neurosurgery 48:441–443CrossRefPubMed Pollock BE, Stafford SL (2001) Stereotactic radiosurgery for recurrent central neurocytoma: case report. Neurosurgery 48:441–443CrossRefPubMed
10.
Zurück zum Zitat Becker M, Schroth G, Zbaren P et al (1997) Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. Radiographics 17:5–26PubMed Becker M, Schroth G, Zbaren P et al (1997) Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. Radiographics 17:5–26PubMed
11.
Zurück zum Zitat Anderson RC, Elder JB, Parsa AT et al (2001) Radiosurgery for the treatment of recurrent central neurocytomas. Neurosurgery 48:1231–1237. discussion 1237–1238CrossRefPubMed Anderson RC, Elder JB, Parsa AT et al (2001) Radiosurgery for the treatment of recurrent central neurocytomas. Neurosurgery 48:1231–1237. discussion 1237–1238CrossRefPubMed
12.
Zurück zum Zitat Bertalanffy A, Roessler K, Dietrich W et al (2001) Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report. J Neurol Neurosurg Psychiatry 70:489–493CrossRefPubMed Bertalanffy A, Roessler K, Dietrich W et al (2001) Gamma knife radiosurgery of recurrent central neurocytomas: a preliminary report. J Neurol Neurosurg Psychiatry 70:489–493CrossRefPubMed
13.
Zurück zum Zitat Cobery ST, Noren G, Friehs GM et al (2001) Gamma knife surgery for treatment of central neurocytomas. Report of four cases. J Neurosurg 94:327–330CrossRefPubMed Cobery ST, Noren G, Friehs GM et al (2001) Gamma knife surgery for treatment of central neurocytomas. Report of four cases. J Neurosurg 94:327–330CrossRefPubMed
14.
Zurück zum Zitat Hara M, Aoyagi M, Yamamoto M et al (2003) Rapid shrinkage of remnant central neurocytoma after gamma knife radiosurgery: a case report. J Neurooncol 62:269–273CrossRefPubMed Hara M, Aoyagi M, Yamamoto M et al (2003) Rapid shrinkage of remnant central neurocytoma after gamma knife radiosurgery: a case report. J Neurooncol 62:269–273CrossRefPubMed
15.
Zurück zum Zitat Javedan SP, Manwaring K, Smith KA (2003) Treatment of posterior third ventricular central neurocytoma with endoscopic biopsy, endoscopic third ventriculostomy and stereotactic radiosurgery. Minim Invasive Neurosurg 46:165–168CrossRefPubMed Javedan SP, Manwaring K, Smith KA (2003) Treatment of posterior third ventricular central neurocytoma with endoscopic biopsy, endoscopic third ventriculostomy and stereotactic radiosurgery. Minim Invasive Neurosurg 46:165–168CrossRefPubMed
16.
Zurück zum Zitat Kim CY, Paek SH, Kim DG (2003) Linear accelerator radiosurgery for central neurocytoma: a case report. J Neurooncol 61:249–254CrossRefPubMed Kim CY, Paek SH, Kim DG (2003) Linear accelerator radiosurgery for central neurocytoma: a case report. J Neurooncol 61:249–254CrossRefPubMed
17.
Zurück zum Zitat Martin JM, Katati M, Lopez E et al (2003) Linear accelerator radiosurgery in treatment of central neurocytomas. Acta Neurochir (Wien) 145:749–754. discussion 754CrossRef Martin JM, Katati M, Lopez E et al (2003) Linear accelerator radiosurgery in treatment of central neurocytomas. Acta Neurochir (Wien) 145:749–754. discussion 754CrossRef
18.
Zurück zum Zitat Maruyama I, Sadato N, Waki A et al (1999) Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study. J Nucl Med 40:1085–1090PubMed Maruyama I, Sadato N, Waki A et al (1999) Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study. J Nucl Med 40:1085–1090PubMed
19.
Zurück zum Zitat Moussa R, Abadjian G, Nader M et al (2004) Central neurocytoma. Four patients. Neurochirurgie 50:639–646CrossRefPubMed Moussa R, Abadjian G, Nader M et al (2004) Central neurocytoma. Four patients. Neurochirurgie 50:639–646CrossRefPubMed
20.
Zurück zum Zitat Leenstra JL, Rodriguez FJ, Frechette CM et al (2007) Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 67:1145–1154CrossRefPubMed Leenstra JL, Rodriguez FJ, Frechette CM et al (2007) Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 67:1145–1154CrossRefPubMed
21.
Zurück zum Zitat Rades D, Schild SE (2006) Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer 106:1140–1143CrossRefPubMed Rades D, Schild SE (2006) Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Cancer 106:1140–1143CrossRefPubMed
Metadaten
Titel
Long-term outcome of conventional radiation therapy for central neurocytoma
verfasst von
Sun Ha Paek
Jung-Ho Han
Jin Wook Kim
Chul-Kee Park
Hee-Won Jung
Sung-Hye Park
Il Han Kim
Dong Gyu Kim
Publikationsdatum
01.10.2008
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2008
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-008-9622-5

Weitere Artikel der Ausgabe 1/2008

Journal of Neuro-Oncology 1/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.